Association between nirsevimab coverage and pediatric emergency department visits for bronchiolitis in 12 European countries: An interrupted time-series analysis

Using an interrupted time-series analysis, Léa Lenglart and colleagues explore whether heterogeneity in coverage in European countries of the RSV- targeting monoclonal antibody nirsevimab associates with differences in case counts of bronchiolitis in infants.